🇯🇵 Uptravi in Japan

PMDA authorised Uptravi on 25 August 2021

Marketing authorisations

PMDA — authorised 25 August 2021

  • Marketing authorisation holder: NIPPON SHINYAKU Co., Ltd
  • Status: approved

Uptravi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Uptravi approved in Japan?

Yes. PMDA authorised it on 25 August 2021; PMDA has authorised it.

Who is the marketing authorisation holder for Uptravi in Japan?

NIPPON SHINYAKU Co., Ltd holds the Japanese marketing authorisation.